Tissue biocompatibility of a new caprolactone-coated self-reinforced self-expandable poly-L-lactic acid bioabsorbable urethral stent

Journal of Endourology

Volumn 13, Issue 7, 1999, Pages 525-530

  Isotalo, Taina ^a,c   Halasz, Andrea ^b   Talja, Martti ^c   Tammela, Teuvo L J ^a   Paasimaa, Senja ^e   Törmälä, Pertti ^d  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b Central Hospital   (Finland)

^c PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

COPOLYMER; LACTONE; POLYLACTIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CYTOTOXICITY; FOREIGN BODY; INFLAMMATION; MALE; NONHUMAN; POLITEF IMPLANT; PRIORITY JOURNAL; RABBIT; STENT; TOXICITY TESTING; URETHRA;

EID: 0032735245     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.1999.13.525     Document Type: Article

References (13)

1. Rokkanen P, Böstman O, Hirvensalo E, et al. The use of absorbable internal fracture fixation devices. Adv Biomater 1992;10:447.
2. Kemppainen E, Talja M, Riihelä M, et al. A bioresorbable urethral stent: An experimental study. Urol Res 1993;21:235.
3. Petas A, Talja M, Tammela TLJ, et al. A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stent to suprapubic catheter and indwelling catheter after visual laser ablation of the prostate. J Urol 1997;157:173.
4. Talja M, Tammela TLJ, Petas A, et al. Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate: Laser prostatectomy. J Urol 1995;154:2089.
5. Dahlstrand C, Grundtman S, Pettersson S: High energy TUMT and the use of resorbable stent for large benign prostatic hyperplasia (abstract 975). Eur Urol 1996;30(suppl 2).
6. Isotalo T, Tammela TLJ, Talja M, et al. A bioabsorbable self expandable self-reinforced poly-L-lactic acid urethral stent for recurrent urethral strictures: A preliminary report. J Urol 1998;160:2033-2036.
7. Isotalo T, Tammela TLJ, Talja M, et al. Bioabsorbable SR-PLLA urethral stent combined with finasteride therapy in the management of acute urinary retention (abstract P9-17). J Endourol 1997;11 (Suppl).
8. Talja M, Välimaa T, Tammela TLJ, et al. Bioabsorbable and biodegradable stents in urology. J Endourol 1997;11:391.
9. Isotalo T, Talja M, Tammela TLJ, et al. Cytotoxicity testing of a new caprolactone-coated self-expanding bioabsorbable SR-PLLA urethral stent. Urol Res 1999;27:149-152.
10. International Standards Organization. Biological evaluation of medical devices 6: Tests for local effects after implantation. Evaluation and testing. ISO 10993-6, 1994.
11. Bergsma J, Rozema F, Bos R et al. Biocompatibility and degradation mechanisms of predegraded and non-degraded poly(lactide) implants: an animal study. Mater Med 1995;6:715.
12. Oosterlink V. Endoscopic urethroplasty with a free skin graft around resorbable polyglycolic acid urethral stent (abstract 668). Eur Urol 1996;30(suppl 2).
13. Välimaa T, Talja M, Tammela TLJ et al. Expansion properties of self-reinforced self-expanding bioabsorbable prostatic stents (abstract P6-10). J Endourol 1998;12(suppl 1).